Sanofi Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (69)

Latest Posts

About This Stock More About This Stock
Forget Teva, Buy These 4 Drug Stocks Instead
Article By: Arpita Dutt
Friday, August 11, 2017 1:17 PM EDT
It’s not been a good quarter for Israel-based generic drug maker, Teva Pharmaceutical Industries Limited. Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017.
In this article: SNY, ALXN, REGN, GILD, TEVA
Read
Bayer (BAYRY) Q2 Earnings Beat, Sales Miss, Cuts Guidance
Article By: Zacks Investment Research
Thursday, July 27, 2017 10:00 AM EDT
Bayer AG’s second-quarter 2017 core earnings per share from continuing operations was $1.99. Earnings were down 12.7% year over year from $2.28 per share.
In this article: ENZ, MON, SNY, BAYRY
Read
3 Large Cap Pharma Stocks To Buy Now
Article By: Zacks Investment Research
Monday, June 12, 2017 3:59 PM EDT
The healthcare sector has dominated headlines this year thanks to promises from the GOP and the Trump administration related to repealing and replacing Obamacare.
In this article: SNY, BAYRY, HLUYY
Read
5 Drug Stocks In Focus On World MS Day
Article By: Arpita Dutt
Wednesday, May 31, 2017 11:23 AM EDT
The multiple sclerosis market represents huge commercial potential. Here are some of the key players in the MS market.
In this article: BIIB, TEVA, NVS, SNY, RHHBY
Read
If You Own Just One Pharma Stock, Make It This
Article By: Michael A Robinson
Wednesday, April 26, 2017 6:42 AM EDT
For the biggest possible pharma profits, investors have to look ahead into the firm's "pipeline," its arsenal of yet-to-be-released drugs that's critical to keeping a drug company competitive in the long term.
In this article: SNY Also: REGN, GILD, FLXN
Read

PARTNER HEADLINES

Latest Tweets for $SNY

No tweets yet!